EUDA Health Holdings Limited (NASDAQ:EUDA - Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 99,200 shares, an increase of 72.8% from the September 15th total of 57,400 shares. Currently, 0.5% of the company's stock are sold short. Based on an average trading volume of 115,400 shares, the short-interest ratio is presently 0.9 days. Based on an average trading volume of 115,400 shares, the short-interest ratio is presently 0.9 days. Currently, 0.5% of the company's stock are sold short.
EUDA Health Trading Down 6.8%
Shares of EUDA Health stock traded down $0.23 during trading hours on Tuesday, reaching $3.15. The company's stock had a trading volume of 57,733 shares, compared to its average volume of 102,697. The company's 50 day simple moving average is $2.11 and its 200 day simple moving average is $3.04. EUDA Health has a one year low of $1.03 and a one year high of $6.30.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a "sell (d)" rating on shares of EUDA Health in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy".
Get Our Latest Analysis on EUDA
About EUDA Health
(
Get Free Report)
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EUDA Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.
While EUDA Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.